Low global SARS-CoV-2 circulation and widespread population immunity from prior infections plus vaccination drive the 95.6% market-implied odds against a new coronavirus pandemic in 2026. Official WHO and CDC surveillance through September shows test positivity rates near 1-3% in most regions, with tens of thousands of cases and under 200 deaths reported in recent 28-day windows—levels consistent with endemic seasonal patterns rather than exponential growth. Current variants under monitoring exhibit immune escape but no increase in severity or transmissibility compared with prior Omicron lineages. A late-summer uptick in cases reflects typical respiratory virus dynamics amid travel and school reopenings, yet hospitalizations and fatalities remain far below pandemic thresholds. A novel bat betacoronavirus was recently sequenced, though it remains confined to animal reservoirs. Continued genomic monitoring and sentinel data releases through year-end will confirm whether any variant shifts alter this trajectory.